HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fetal Weight

The weight of the FETUS in utero. It is usually estimated by various formulas based on measurements made during PRENATAL ULTRASONOGRAPHY.
Also Known As:
Body Weights, Fetal; Fetal Body Weight; Fetal Body Weights; Fetal Weights; Weight, Fetal; Weights, Fetal; Body Weight, Fetal
Networked: 1776 relevant articles (65 outcomes, 104 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Fetal Growth Retardation (Intrauterine Growth Retardation)
2. Body Weight (Weight, Body)
3. Fetal Weight
4. Birth Weight (Birth Weights)
5. Cleft Palate (Palate, Cleft)

Experts

1. Chan, Wen-Hsiung: 19 articles (05/2019 - 11/2006)
2. Wang, Hui: 11 articles (03/2022 - 11/2011)
3. Figueras, F: 8 articles (01/2021 - 03/2015)
4. Jaddoe, Vincent W V: 8 articles (01/2021 - 03/2010)
5. Newnham, John P: 8 articles (01/2021 - 11/2003)
6. Wang, Hua: 8 articles (01/2021 - 01/2006)
7. Wu, Guoyao: 8 articles (12/2020 - 02/2010)
8. Khalil, Asma: 7 articles (01/2022 - 01/2015)
9. Morales-Roselló, José: 7 articles (01/2022 - 01/2015)
10. Chen, Yuan-Hua: 7 articles (01/2021 - 01/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Fetal Weight:
1. Insulin (Novolin)FDA Link
2. Sildenafil Citrate (Viagra)FDA Link
01/01/2016 - "There are some new studies which have demonstrated the role of sildenafil citrate in improving vasodilatation of small myometrial vessels and therefore improvement in amniotic fluid index, fetal weight, and even uterine and umbilical artery Doppler patterns. "
01/01/2016 - "Sildenafil treatment also improved uterine blood flow, decreased uterine vascular resistance, and improved fetal weights in comparison with untreated sFlt1-expressing mice. "
01/01/2020 - "This was a cardiovascular substudy within a UK multicenter, placebo-controlled trial, in which 135 women with a singleton pregnancy and severe early-onset FGR (defined as a combination of estimated fetal weight or abdominal circumference below the 10th centile and absent/reversed end-diastolic flow in the umbilical artery on Doppler velocimetry, diagnosed between 22 + 0 and 29 + 6 weeks' gestation) were assigned randomly to receive either 25 mg sildenafil three times daily or placebo until 32 + 0 weeks' gestation or delivery. "
01/01/2020 - "Out of 360 planned participants, a total of 216 pregnant women were included, with 108 women randomized to sildenafil (median gestational age at randomization, 24 weeks 5 days [interquartile range, 23 weeks 3 days to 25 weeks 5 days]; mean [SD] estimated fetal weight, 458 [160] g) and 108 women randomized to placebo (median gestational age, 25 weeks 0 days [interquartile range, 22 weeks 5 days to 26 weeks 3 days]; mean [SD] estimated fetal weight, 464 [186] g). "
01/01/2019 - "A significant increase of 222.58 grams [27.75 to 417.41] was observed in the fetal weight at birth of patients taking sildenafil. "
3. Ethanol (Ethyl Alcohol)IBA
4. Blood Glucose (Blood Sugar)IBA
5. SmokeIBA
6. Arginine (L-Arginine)FDA Link
7. Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
8. Liver GlycogenIBA
9. Methionine (L-Methionine)FDA Link
10. Tretinoin (Retinoic Acid)FDA LinkGeneric
03/01/1997 - "Group IV had significantly reduced mean fetal body weight (p < or = 0.01) and a greater frequency of resorptions compared with group I. Although external, visceral, or skeletal alterations occurred at significantly greater levels in group III, they were unrelated to tretinoin administration because the fetal incidences were not dosage dependent, and the litter incidence did not significantly differ from the control group values. "
01/01/2005 - "Administration of retinoic acid at all doses resulted in statistically significant decreases in mean fetal weight and mean fetal height and the increase in mortality rate, and caused severe ultrastructural damages in Meckel's cartilage. "
03/01/1997 - "Maternally toxic dosages of tretinoin were associated with an increased incidence of abortions and resorptions and reduced fetal body weight, two end points of developmental toxicity. "
01/01/2005 - "Folic acid administration prevented the decrease in mean fetal weight and height of the embryos treated with retinoic acid of 40 mg/kg. In addition, there was a marked decrease in the number of degenerated chondrocytes and an improvement in the structure of granular endoplasmic reticulum along with intact nuclei. "
02/01/1996 - "Under the conditions here, simultaneous administration of Ro 31-0521 with all-trans-retinoic acid appeared to reduce the total percentage of abnormal fetuses seen after exposure to retinoic acid alone, but fetal body weights remained depressed and the numbers of dead embryos remained elevated, suggesting only limited influence of the cyclohexanetrione on retinoid developmental toxicity."

Therapies and Procedures

1. Induced Labor
2. Cesarean Section (Caesarean Section)
01/01/1992 - "Due to inherent uncertainty regarding appropriate management and observed variability of response, we conclude that studies be performed to assess objectively safety and efficacy of cesarean section for fetal indications at less than 26 weeks' gestation or less than 750 gm estimated fetal weight."
03/01/2023 - "The aims of this study were to compare the screening performance of the Society for Maternal-Fetal Medicine (SMFM) biometric criteria (estimated fetal weight (EFW) or abdominal circumference (AC) < 10th centile) with that of the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG)-endorsed Delphi consensus criteria for late FGR for delivery of a small-for-gestational-age (SGA) infant at term, emergency Cesarean section (CS) for non-reassuring fetal status (NRFS), perinatal mortality and composite severe neonatal morbidity. "
03/01/2010 - "This study compared the accuracy of ultrasound, clinical and maternal estimates of fetal weight in 246 parous women with singleton, term pregnancies admitted for scheduled caesarean section. "
10/10/2002 - "Predictive values of clinical and ultrasonographic estimations of fetal weight for diagnosing macrosomia, defined for the purpose of this study as 4000 g or more, and their effect on the rate of cesarean sections. "
03/01/1997 - "The objective of this study was to prospectively evaluate the utility of the maternal-fetal ratio (MFR) with clinical and sonographic estimates of fetal weight (FEW) for predicting active phase arrest disorders and the need for a subsequent cesarean section (C/S). "
3. Prenatal Care (Care, Prenatal)
4. Therapeutics
5. Aftercare (After-Treatment)